These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28042340)

  • 1. Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
    Fan B; Kang L; Chen L; Sun P; Jin M; Wang Q; Bae YH; Huang W; Gao Z
    Theranostics; 2017; 7(2):357-376. PubMed ID: 28042340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
    Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
    ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH-Activated Targeting Drug Delivery System Based on the Selective Binding of Phenylboronic Acid.
    Zhao D; Xu JQ; Yi XQ; Zhang Q; Cheng SX; Zhuo RX; Li F
    ACS Appl Mater Interfaces; 2016 Jun; 8(23):14845-54. PubMed ID: 27229625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-activated decrosslinking and charge-reversal vectors for siRNA delivery and cancer therapy.
    Zhou Z; Zhang Q; Zhang M; Li H; Chen G; Qian C; Oupicky D; Sun M
    Theranostics; 2018; 8(17):4604-4619. PubMed ID: 30279726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylboronic acid-sugar grafted polymer architecture as a dual stimuli-responsive gene carrier for targeted anti-angiogenic tumor therapy.
    Kim J; Lee YM; Kim H; Park D; Kim J; Kim WJ
    Biomaterials; 2016 Jan; 75():102-111. PubMed ID: 26491998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple-Layered pH-Responsive Micelleplexes Loaded with siRNA and Cisplatin Prodrug for NF-Kappa B Targeted Treatment of Metastatic Breast Cancer.
    Yu H; Guo C; Feng B; Liu J; Chen X; Wang D; Teng L; Li Y; Yin Q; Zhang Z; Li Y
    Theranostics; 2016; 6(1):14-27. PubMed ID: 26722370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel.
    Tang S; Yin Q; Su J; Sun H; Meng Q; Chen Y; Chen L; Huang Y; Gu W; Xu M; Yu H; Zhang Z; Li Y
    Biomaterials; 2015 Apr; 48():1-15. PubMed ID: 25701027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible Shielding between Dual Ligands for Enhanced Tumor Accumulation of ZnPc-Loaded Micelles.
    Cao J; Gao X; Cheng M; Niu X; Li X; Zhang Y; Liu Y; Wang W; Yuan Z
    Nano Lett; 2019 Mar; 19(3):1665-1674. PubMed ID: 30801190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.
    Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J
    Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
    Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinspired nanoplatform for enhanced delivery efficiency of doxorubicin into nucleus with fast endocytosis, lysosomal pH-triggered drug release, and reduced efflux.
    Huang Y; Xu Y; Wu Y; Chen T; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110413. PubMed ID: 31401461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
    Fang L; Zhang W; Wang Z; Fan X; Cheng Z; Hou X; Chen D
    Drug Deliv; 2019 Dec; 26(1):1125-1139. PubMed ID: 31736389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.